Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

ACCURAY Aktie

 >ACCURAY Aktienkurs 
0.202 EUR    +2.8%    (TradegateBSX)
Ask: 0.2 EUR / 50000 Stück
Bid: 0.18 EUR / 55600 Stück
Tagesumsatz: 1000 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ACCURAY Aktie über LYNX handeln
>ACCURAY Performance
1 Woche: -0,2%
1 Monat: -14,8%
3 Monate: -27,9%
6 Monate: -36,9%
1 Jahr: -85,8%
laufendes Jahr: -70,5%
>ACCURAY Aktie
Name:  ACCURAY INC. DL -,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US0043971052 / A0MKWM
Symbol/ Ticker:  XEJ (Frankfurt) / ARAY (NASDAQ)
Kürzel:  FRA:XEJ, ETR:XEJ, XEJ:GR, NASDAQ:ARAY
Index:  -
Profil:  Accuray Incorporated is a medical device company that develops, manufactures, sells, and supports advanced radiation therapy systems for cancer treatment. The company’s portfolio centers on the CyberKnife and Radixact platforms, which are designed ..
>Volltext..
Marktkapitalisierung:  22.55 Mio. EUR
Unternehmenswert:  150.64 Mio. EUR
Umsatz:  352.85 Mio. EUR
EBITDA:  1.78 Mio. EUR
Nettogewinn:  -43.19 Mio. EUR
Gewinn je Aktie:  -0.36 EUR
Schulden:  164.78 Mio. EUR
Liquide Mittel:  36.2 Mio. EUR
Operativer Cashflow:  -6.13 Mio. EUR
Bargeldquote:  0.22
Umsatzwachstum:  -9.58%
Gewinnwachstum:  -3089.29%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  ACCURAY
Letzte Datenerhebung:  27.09.26
>ACCURAY Kennzahlen
Aktien/ Unternehmen:
Aktien: 119.44 Mio. St.
Frei handelbar: 95.59%
Rückkaufquote: -2.59%
Mitarbeiter: 809
Umsatz/Mitarb.: 0.44 Mio. EUR
Analysten:
Analystenrating: No rating
Kursziel: -
Bewertung:
KGV: -
KGV lG: -
KUV: 0.07
KBV: 0.68
PEG-Ratio: -
EV/EBITDA: 84.62
Rentabilität:
Bruttomarge: 27.71%
Gewinnmarge: -12.24%
Operative Marge: -2.88%
Managementeffizenz:
Gesamtkaprendite: -10.77%
Eigenkaprendite: -80.08%
>ACCURAY Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Onkologie/ Krebs- Behandlung
 
27.09.26 - 17:18
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform (PR Newswire)
 
MADISON, Wis., Sept. 27, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogica") to pursue advanced volumetric imaging capabilities for the CyberKnife® System.......
11.09.26 - 17:33
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray′s Online Adaptive Capabilities (PR Newswire)
 
MADISON, Wis., Sept. 11, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing for an expanded......
26.08.26 - 23:36
Accuray (ARAY) Q4 2026 Earnings Call Transcript (Fool)
 
Transformation plan delivered $20M in cost savings as China headwinds pressured product revenue 42%....
20.08.26 - 01:15
Accuray expects $15M of incremental annualized cost and margin improvement in FY27 while withholding formal revenue and adjusted EBITDA guidance (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.08.26 - 23:24
Accuray meldet gemischte Q4-Ergebnisse: Umsatz enttäuscht, Aktie unter Druck (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
19.08.26 - 22:09
Accuray GAAP EPS of -$0.02 beats by $0.08, revenue of $100.92M misses by $4.38M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.08.26 - 22:06
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results (PR Newswire)
 
MADISON, Wis., Aug. 19, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2026, ended June 30, 2026. Key Highlights The Company's transformation plan delivered more than $20 million of cost and margin improvement......
18.08.26 - 23:42
Accuray Q4 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.08.26 - 23:12
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments (PR Newswire)
 
MADISON, Wis., Aug. 12, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced two key leadership appointments intended to improve operational execution and profitability, deliver increased customer value, and enhance overall enterprise performance as the company continues to......
05.08.26 - 22:06
Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026 (PR Newswire)
 
MADISON, Wis., Aug. 5, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2026, ended June 30, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on August 19, 2026. The......
30.07.26 - 00:30
Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation (PR Newswire)
 
MADISON, Wis., July 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced a plan incorporating several decisive actions that will drive a significant improvement in its financial position, a......
29.05.26 - 22:12
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules (PR Newswire)
 
MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Commercial Officer and David Shin, the company's new Chief Legal Officer. As material......
15.05.26 - 22:06
Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer (PR Newswire)
 
MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive......
07.05.26 - 19:36
This PayPal Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday (Benzinga)
 
Wall Street analysts changed outlook on top names, downgraded Amplitude Inc, Accuray Inc, Angi Inc, PayPal Holdings, and Criteo S.A. See analyst ratings. Importance Rank:  1 read more...
07.05.26 - 16:09
Accuray stock tumbles after earnings miss, guidance withdrawal (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.05.26 - 10:48
Accuray withdraws guidance amid Middle East disruptions while targeting $25M annualized profitability improvement in fiscal 2027 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.05.26 - 00:36
Accuray (ARAY) Q3 2026 Earnings Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
06.05.26 - 23:18
Accuray verfehlt Prognosen für Q3 2026 – Aktie gibt nach (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
06.05.26 - 22:09
Accuray Reports Fiscal 2026 Third Quarter Financial Results (PR Newswire)
 
MADISON, Wis., May 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026. Key Highlights Transformation plan delivering ahead of expectations, with approximately $10 million of cost and margin improvements......
22.04.26 - 22:06
Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026 (PR Newswire)
 
MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026. The......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Aus einem Weisen wird man nicht klug. - Elazar Benyoetz
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!